Enantioselective C–H Functionalization Recent Advances and Applications in Drug Discovery – A Review

References

[1] Allen, D. (2016). Where will we get the next generation of medicinal chemists? Drug Discovery Today, 21, 704–706.

[2] Blakemore, D. C., Doyle, P. M., & Fobian, Y. M. (Eds.). (2016). Synthetic methods in drug discovery (Vol. 2). Royal Society of Chemistry.

[3] Brady, P. B., & Bhat, V. (2017). Recent applications of Rh- and Pd-catalyzed C(sp³)–H functionalization in natural product total synthesis. European Journal of Organic Chemistry, 5179–5190.

[4] Brooks, A. F., Topczewski, J. J., Ichiishi, N., Sanford, M. S., & Scott, P. J. H. (2014). Late-stage [18F]fluorination: New solutions to old problems. Chemical Science, 5, 4545–4553.

[5] Brueckl, T., Baxter, R. D., Ishihara, Y., & Baran, P. S. (2012). C–H functionalization logic in total synthesis. Accounts of Chemical Research, 45, 826–839.

[6] Buitrago Santanilla, A., et al. (2015). Nanomole-scale high-throughput chemistry for the synthesis of complex molecules. Science, 347, 49–53.

[7] Campbell, M. G., & Ritter, T. (2014). Late-stage fluorination: From fundamentals to application. Organic Process Research & Development, 18, 474–480.

[8] Cernak, T., Dykstra, K. D., Tyagarajan, S., Vachal, P., & Krska, S. W. (2016). The medicinal chemist’s toolbox for late-stage functionalization of drug-like molecules. Chemical Society Reviews, 45, 546–576.

[9] Cherney, E. C., Lopchuk, J. M., Green, J. C., & Baran, P. S. (2014). A unified approach to ent-atisane diterpenes and related alkaloids: Synthesis of (−)-Methyl Atisenoate, (−)-Isoatisine, and the Hetidine skeleton. Journal of the American Chemical Society, 136, 12592–12595.

[10] Collins, K. D., & Glorius, F. (2013). A robustness screen for the rapid assessment of chemical reactions. Nature Chemistry, 5, 597–601.

[11] Durak, L. J., Payne, J. T., & Lewis, J. C. (2016). Late-stage diversification of biologically active molecules via chemoenzymatic C–H functionalization. ACS Catalysis, 6, 1451–1454.

[12] Eastgate, M. D., Schmidt, M. A., & Fandrick, K. R. (2017). On the design of complex drug candidate syntheses in the pharmaceutical industry. Nature Reviews Chemistry, 1, Article 0016.

[13] Fier, P. S., & Hartwig, J. F. (2013). Selective C–H fluorination of pyridines and diazines inspired by a classic amination reaction. Science, 342, 956–960.

[14] Flick, A. C., et al. (2017). Synthetic approaches to the new drugs approved during 2015. Journal of Medicinal Chemistry, 60, 6480–6515.

[15] Foley, D. J., Nelson, A., & Marsden, S. P. (2016). Evaluating new chemistry to drive molecular discovery: Fit for purpose? Angewandte Chemie International Edition, 55, 13650–13657.

[16] Fox, J. C., Gilligan, R. E., Pitts, A. K., Bennett, H. R., & Gaunt, M. J. (2016). The total synthesis of K-252c (staurosporinone) via a sequential C–H functionalisation strategy. Chemical Science, 7, 2706–2710.

[17] Gensch, T., Teders, M., & Glorius, F. (2017). Approach to comparing the functional group tolerance of reactions. Journal of Organic Chemistry, 82, 9154–9159.

[18] Goldberg, F. W., Kettle, J. G., Kogej, T., Perry, M. W. D., & Tomkinson, N. P. (2015). Designing novel building blocks is an overlooked strategy to improve compound quality. Drug Discovery Today, 20, 11–17.

[19] Gutekunst, W. R., & Baran, P. S. (2011). C–H functionalization logic in total synthesis. Chemical Society Reviews, 40, 1976–1991.

[20] Kilpin, K. J., & Whitby, R. J. (2015). Chemistry Central Journal themed issue: Dial-a-molecule. Chemistry Central Journal. https://doi.org/10.1186/s13065-015-0122-3

[21] Kutchukian, P. S., et al. (2016). Chemistry informer libraries: A chemoinformatics-enabled approach to evaluate and advance synthetic methods. Chemical Science, 7, 2604–2613.

[22] Liao, K., Negretti, S., Musaev, D. G., Bacsa, J., & Davies, H. M. L. (2016). Site-selective and stereoselective functionalization of unactivated C–H bonds. Nature, 533, 230–234.

[23] Liu, W., & Groves, J. T. (2015). Manganese-catalyzed C–H halogenation. Accounts of Chemical Research, 48, 1727–1735.

[24] McCallum, M. E., Rasik, C. M., Wood, J. L., & Brown, M. K. (2016). Collaborative total synthesis: Routes to (±)-Hippolachnin A enabled by quadricyclane cycloaddition and late-stage C–H oxidation. Journal of the American Chemical Society, 138, 2437–2442.

[25] McMurray, L., O’Hara, F., & Gaunt, M. J. (2011). Recent developments in natural product synthesis using metal-catalysed C–H bond functionalisation. Chemical Society Reviews, 40, 1885–1898.

[26] Meanwell, M., Nodwell, M. B., Martin, R. E., & Britton, R. (2016). A convenient late-stage fluorination of pyridylic C–H bonds with N-fluorobenzenesulfonimide. Angewandte Chemie International Edition, 55, 13244–13248.

[27] Meng, Z., Yu, H., Li, L., Tao, W. Y., Chen, H., Wan, M., Yang, P., Edmonds, D. J., Zhang, J., & Li, A. (2015). Total synthesis and antiviral activity of indolosesquiterpenoids from the xiamycin and oridamycin families. Nature Communications, 6096.

[28] Mercer, J. A., Cohen, C. M., Shuken, S. R., Wagner, A. M., Smith, M. W., Moss, F. R., Smith, M. D., Vahala, R., Martinez, A. G., Boxer, S. G., & Burns, N. Z. (2016). Chemical synthesis and self-assembly of a ladderane phospholipid. Journal of the American Chemical Society, 138, 15845–15848.

[29] Michaudel, Q., Ishihara, Y., & Baran, P. S. (2015). Academia–industry symbiosis in organic chemistry. Accounts of Chemical Research, 48, 712–721.

[30] Nadin, A., Hattotuwagama, C., & Churcher, I. (2012). Lead-oriented synthesis: A new opportunity for synthetic chemistry. Angewandte Chemie International Edition, 51, 1114–1122.

[31] Newhouse, T., & Baran, P. S. (2011). If C–H bonds could talk: Selective C–H bond oxidation. Angewandte Chemie International Edition, 50, 3362–3374.

[32] Nielsen, M. K., Ugaz, C. R., Li, W., & Doyle, A. G. (2015). PyFluor: A low-cost, stable, and selective deoxyfluorination reagent. Journal of the American Chemical Society, 137, 9571–9574.

[33] Osberger, T. J., Rogness, D. C., Kohrt, J. T., Stepan, A. F., & White, M. C. (2016). Oxidative diversification of amino acids and peptides by small-molecule iron catalysis. Nature, 537, 214–219.

[34] Panish, R. A., Chintala, S. R., & Fox, J. M. (2016). A mixed-ligand chiral rhodium(II) catalyst enables the enantioselective total synthesis of Piperarborenine B. Angewandte Chemie International Edition, 55, 4983–4987.

[35] Prier, C. K., Rankic, D. A., & MacMillan, D. W. C. (2013). Visible light photoredox catalysis with transition metal complexes: Applications in organic synthesis. Chemical Reviews, 113, 5322–5363.

[36] Purser, S., Moore, P. R., Swallow, S., & Gouverneur, V. (2008). Fluorine in medicinal chemistry. Chemical Society Reviews, 37, 320–330.

[37] Rasik, C. M., & Brown, M. K. (2014). Total synthesis of Gracilioether F: Development and application of Lewis acid promoted ketene–alkene [2+2] cycloadditions and late-stage C–H oxidation. Angewandte Chemie International Edition, 53, 14522–14526.

[38] Romero, N. A., & Nicewicz, D. A. (2016). Organic photoredox catalysis. Chemical Reviews, 116, 10075–10166.

[39] Sharpe, R. J., & Johnson, J. S. (2015). A global and local desymmetrization approach to the synthesis of steroidal alkaloids: Stereocontrolled total synthesis of paspaline. Journal of the American Chemical Society, 137, 4968–4971.

[40] Shevlin, M. (2017). Practical high-throughput experimentation for chemists. ACS Medicinal Chemistry Letters, 8, 601–607.

[41] Siler, D. A., Mighion, J. D., & Sorensen, E. J. (2014). An enantiospecific synthesis of Jiadifenolide. Angewandte Chemie International Edition, 53, 5332–5335.

[42] Wang, B., Liu, Y., Jiao, R., Feng, Y. Q., Li, Q., Chen, C., Liu, L., He, G., & Chen, G. (2016). Total synthesis of Mannopeptimycins α and β. Journal of the American Chemical Society, 138, 3926–3932.

[43] White, M. C. (2012). Adding aliphatic C–H bond oxidations to synthesis. Science, 335, 807–809.

[44] Wu, Q.-F., et al. (2017). Formation of α-chiral centers by asymmetric β-C(sp³)–H arylation, alkenylation, and alkynylation. Science, 355, 499–503.

[45] Xu, Z. J., & Wu, Y. K. (2017). Efficient synthetic routes to (±)-Hippolachnin A, (±)-Gracilioethers E and F and the alleged structure of (±)-Gracilioether I. Chemistry – A European Journal, 23, 2026–2030.

[46] Yamada, S., Gavryushin, A., & Knochel, P. (2010). Convenient electrophilic fluorination of functionalized aryl and heteroaryl magnesium reagents. Angewandte Chemie International Edition, 49, 2215–2218.

[47] Yamaguchi, J., Yamaguchi, A. D., & Itami, K. (2012). C–H bond functionalization: Emerging synthetic tools for natural products and pharmaceuticals. Angewandte Chemie International Edition, 51, 8960–9009.

[48] Zhang, X., & MacMillan, D. W. C. (2016). Alcohols as latent coupling fragments for metallaphotoredox catalysis: sp³–sp² cross-coupling of oxalates with aryl halides. Journal of the American Chemical Society, 138, 13862–13865.

[49] Zhang, Z., Tanaka, K., & Yu, J.-Q. (2017). Remote site-selective C–H activation directed by a catalytic bifunctional template. Nature, 543, 538–542.

@article{1716808,
      author = {Uduogu, Vera Ifechukwu, Ojelabi Titilayo Bolaji, Aigbokhae-Ogbomon Peace, Ibidunmoye Faith Omotayo, Chidera Favour Onuoha; Adewole Esther Abisola},
      title = {Enantioselective C–H Functionalization Recent Advances and Applications in Drug Discovery – A Review},
      journal = {Iconic Research And Engineering Journals},
      year = {2026},
      volume = {9},
      number = {10},
      pages = {4445-4452},
      issn = {2456-8880},
      url = {https://www.irejournals.com/formatedpaper/1716808.pdf},
      abstract = {C–H functionalization represents a significant paradigm shift in the strategic framework of modern organic synthesis. Traditionally, synthetic methodologies have relied on the selective transformation of pre-installed functional groups, requiring multiple steps for functional group interconversion and protection–deprotection sequences. In contrast, C–H functionalization enables the direct activation and transformation of otherwise inert C–H bonds, allowing for the site-selective introduction of new functional groups within complex molecular architectures, even in the presence of more traditionally reactive functional groups. This approach offers a more atom-economical and step-efficient route to molecular diversification, thereby streamlining synthetic pathways. Despite several decades of pioneering advances in academia, organic synthesis continues to represent a major bottleneck in pharmaceutical research and development. From an industrial perspective, challenges such as achieving high regioselectivity, chemoselectivity, and scalability in C–H activation reactions remain significant. Addressing these limitations would substantially expand the utility of C–H functionalization strategies and accelerate the discovery and development of next-generation therapeutic agents. Significant synthesis challenges arise from the fact that drug molecules typically contain amines and N-heterocycles, as well as unprotected polar groups. There is also a need for new reactions that enable non-traditional disconnection more C–H bond activation and late-stage functionalization, as well as stereoselectively substituted aliphatic hetero cyclic ring synthesis, C–X or C–C bond formation. We also emphasize that syntheses compatible with biomacromolecules will find increasing use, while new technologies such as machine-assisted approaches and artificial intelligence for synthesis planning have the potential to dramatically accelerate the drug-discovery process.},
      keywords = {C-H Functionalization, Nature Product, Total Synthesis, Drug Development},
      month = {April},
      doi = {https://doi.org/10.64388/IREV9I10-1716808}
  }